ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Long-Term Survival Outcomes of Liver Transplantation for Klatskin Tumour: A Comparative Study With Radical Resection Surgery

    A. Hu, X. Zhu, X. He.

    Department of general Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background and aim: Besides radical resection (RR), Liver transplantation (LT) is another suggested surgical modality for hilar cholangiocarcinoma (Klatskin tumour, KT) especially for patients whose…
  • 2015 American Transplant Congress

    Verification of OPTN Hepatocellular Carcinoma Recurrence Data

    J. George,1 K. Eddinger,1 D. Goldberg,2 M. Levine,3 P. Abt.3

    1Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA; 2Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA; 3Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.

    PURPOSE: OPTN data on HCC recurrence is increasingly utilized for a variety of studies; however, the accuracy of this data has not been examined. We…
  • 2015 American Transplant Congress

    An Analysis of Health-Related Quality of Life in Liver Transplantion for Hepatocellular Carcinoma

    C. Kensinger, H. O'Dell, D. LaNeve, L. Simmons, I. Feurer, D. Moore.

    Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN.

    Background:There is a disproportionate waiting time and an unclear survival benefit between hepatocellular carcinoma (HCC) versus non-HCC liver transplant recipients. However, there is paucity of…
  • 2015 American Transplant Congress

    Modified Upper Abdominal Organ Cluster Transplantation: A Serial of 16 Cases in a Single Center

    J. Zhou, W. Ju, X. Yuan, D. Wang, X. Zhu, X. He.

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

    Objectives: Various postoperatively complications and high mortality rate are the major difficulties in early classical total and subtotal abdominal organ transplantation. To improve long-term survival,…
  • 2015 American Transplant Congress

    Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

    S. Lee, S. Kim.

    Liver Cancer Center, National Cancer Center, Goyang, Korea.

    Background: The relevant number of patients with hepatocellular carcinoma (HCC) beyond the Milan criteria has undergone living donor liver transplantation (LDLT). However, the prognostic factors…
  • 2015 American Transplant Congress

    Liver Transplantation for Hepatocellular Carcinoma inside Milan Criteria: Lower Recurrence in Patients With Hepatitis C Infection

    W. Palmer, D. Lee, J. Burns, A. Keaveny, J. Melendez, J. Nguyen, T. Patel, S. Pungpapong, B. Rosser, R. Paz-Fumagalli, R. Nakhleh, K. Musto, D. Harnois.

    Mayo Clinic, Jacksonville, FL.

    Purpose: Hepatitis C infection (HCV) related-cirrhosis can lead to hepatocellular carcinoma (HCC). Liver transplantation (LT) is the optimal treatment for selected patients with HCC, providing…
  • 2015 American Transplant Congress

    Association Between Polymorphisms of PPM1E Gene and Tumor Size of Hepatocellular Carcinoma Patients

    M.-S. Park,1 S.-K. Kim.2

    1Surgery, Kyung Hee University Hospital, Seoul, Korea; 2Pharmacology, Kyung Hee University, Seoul, Korea.

    The protein phosphatase, Mg2+/Mn2+ dependent, 1E (PPM1E) inactivates multiple substrates including 5'-AMP activate protein kinases (AMPK) which inhibits the growth and survival of cancer cells.…
  • 2015 American Transplant Congress

    Recurrence of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) Alone and TACE in Combination With Other Treatment Modalities

    J. Balogh, A. Islam, A. Saharia, H. Monsour, S. Gordon Burroughs, M. Weiner, A. Gaber, R. Ghobrial.

    General Surgery, Houston Methodist Hospital, Houston, TX.

    AIM:Treatment of hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE) can help downstage tumors prior to orthotopic liver transplantation (OLT); however, there is a risk of…
  • 2015 American Transplant Congress

    Long-Term Outcome After Liver Transplantation for Unresectable Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment

    S. Radunz,1 T. Benkoe,1 J. Best,2 A. Bockisch,3 T. Lauenstein,4 H. Baba,5 A. Paul,1 J. Treckmann.1

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany; 3Nuclear Medicine, University Hospital Essen, Essen, Germany; 4Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany; 5Pathology and Neuropathology, University Hospital Essen, Essen, Germany.

    Background: Liver transplantation remains the only curative treatment option for patients with unresectable hepatocellular carcinoma (HCC). Several bridging treatments are employed because the limited availability…
  • 2015 American Transplant Congress

    Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?

    J. Minneman, J. Grijalva, S. Rangel, H. Kim, K. Vakili.

    Surgery, Boston Children's Hospital, Boston, MA.

    Examine the relationship between transplant-related total cost and 1-year graft failure and patient mortality rate for liver transplantation at freestanding children's hospitals.Using the Pediatric Health…
  • « Previous Page
  • 1
  • …
  • 1493
  • 1494
  • 1495
  • 1496
  • 1497
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences